Search research articles
Contact Us
Filters
Showing results (31-40 of 44) with videos related to
Page
of 5
Sort By:
Pharmacogenomics
|
September 12, 2024
Association of DNA methylation, polymorphism and mRNA level of ALAS1 with antituberculosis drug-induced liver injury
Zhuolu Hao, Bing Han, Xinyue Zhou, et al.
Archives of Medical Science : AMS
|
July 15, 2015
The beneficial effects of adjunctive recombinant human interleukin-2 for multidrug resistant tuberculosis
Hong Shen, Rui Min, Qi Tan, et al.
Pharmacogenetics and Genomics
|
November 16, 2025
No interaction between genetic variants and DNA methylation of the ferrochelatase gene in relation to antituberculosis drug-induced liver injury
Fei Wang, Meiling Zhang, Yu Wu, et al.
Journal of Clinical Pharmacy and Therapeutics
|
May 28, 2021
A validation study of the UGT1A4 rs2011404 variant and the risk of anti-tuberculosis drug-induced hepatotoxicity in an Eastern Chinese Han population
Jia Zhu, Wenpei Liu, Meiling Zhang, et al.
Pharmacogenomics
|
December 10, 2025
Whole exome sequencing identifies rare variants involved in PPIX-metabolizing pathway in anti-TB drug-induced hepatitis
Yu Wu, Lihuan Lu, Fei Wang, et al.
The American Journal of Tropical Medicine and Hygiene
|
July 7, 2026
Impact of Diabetes Mellitus on Drug-Induced Liver Injury during Antituberculosis Therapy: A Prospective Cohort Study
Ruina Chen, Yu Wu, Xiaoyan Xu, et al.
Gene
|
April 1, 2014
Genetic polymorphisms of IFNG and IFNGR1 in association with the risk of pulmonary tuberculosis
Jieqiong Lü, Hongqiu Pan, Yongzhong Chen, et al.
Microbiology Spectrum
|
July 7, 2025
Real-world effectiveness and safety of prolonged bedaquiline course in the treatment of drug-resistant tuberculosis-a multi-center retrospective cohort study in a country with a high burden of drug-resistant tuberculosis
Yuanyuan Yu, Jie Cao, Hongqiu Pan, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
November 18, 2022
High accuracy of recombinant fusion protein early secretory antigenic target protein 6-culture filtrate protein 10 skin test for the detection of tuberculosis infection: a phase III, multi-centered, double-blind, hospital-based, randomized controlled trial
Lu Xia, Miao Xu, Feng Li, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 25, 2019
Treatment Outcome of a Shorter Regimen Containing Clofazimine for Multidrug-resistant Tuberculosis: A Randomized Control Trial in China
Yadong Du, Chao Qiu, Xiaohong Chen, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 44) with videos related to
Sort By:
Page
of 5
Pharmacogenomics
|
September 12, 2024
Association of DNA methylation, polymorphism and mRNA level of ALAS1 with antituberculosis drug-induced liver injury
Zhuolu Hao, Bing Han, Xinyue Zhou, et al.
Archives of Medical Science : AMS
|
July 15, 2015
The beneficial effects of adjunctive recombinant human interleukin-2 for multidrug resistant tuberculosis
Hong Shen, Rui Min, Qi Tan, et al.
Pharmacogenetics and Genomics
|
November 16, 2025
No interaction between genetic variants and DNA methylation of the ferrochelatase gene in relation to antituberculosis drug-induced liver injury
Fei Wang, Meiling Zhang, Yu Wu, et al.
Journal of Clinical Pharmacy and Therapeutics
|
May 28, 2021
A validation study of the UGT1A4 rs2011404 variant and the risk of anti-tuberculosis drug-induced hepatotoxicity in an Eastern Chinese Han population
Jia Zhu, Wenpei Liu, Meiling Zhang, et al.
Pharmacogenomics
|
December 10, 2025
Whole exome sequencing identifies rare variants involved in PPIX-metabolizing pathway in anti-TB drug-induced hepatitis
Yu Wu, Lihuan Lu, Fei Wang, et al.
The American Journal of Tropical Medicine and Hygiene
|
July 7, 2026
Impact of Diabetes Mellitus on Drug-Induced Liver Injury during Antituberculosis Therapy: A Prospective Cohort Study
Ruina Chen, Yu Wu, Xiaoyan Xu, et al.
Gene
|
April 1, 2014
Genetic polymorphisms of IFNG and IFNGR1 in association with the risk of pulmonary tuberculosis
Jieqiong Lü, Hongqiu Pan, Yongzhong Chen, et al.
Microbiology Spectrum
|
July 7, 2025
Real-world effectiveness and safety of prolonged bedaquiline course in the treatment of drug-resistant tuberculosis-a multi-center retrospective cohort study in a country with a high burden of drug-resistant tuberculosis
Yuanyuan Yu, Jie Cao, Hongqiu Pan, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
November 18, 2022
High accuracy of recombinant fusion protein early secretory antigenic target protein 6-culture filtrate protein 10 skin test for the detection of tuberculosis infection: a phase III, multi-centered, double-blind, hospital-based, randomized controlled trial
Lu Xia, Miao Xu, Feng Li, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 25, 2019
Treatment Outcome of a Shorter Regimen Containing Clofazimine for Multidrug-resistant Tuberculosis: A Randomized Control Trial in China
Yadong Du, Chao Qiu, Xiaohong Chen, et al.
Page
of 5